• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Callan JMB Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    12/5/25 5:00:27 PM ET
    $CJMB
    Real Estate
    Real Estate
    Get the next $CJMB alert in real time by email
    false 0002032545 0002032545 2025-12-01 2025-12-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): December 1, 2025

     

    Callan JMB Inc.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-42506   99-0931141
    (State or other jurisdiction   (Commission   (I.R.S. Employer
    of incorporation)   File Number)   Identification No.)

     

    244 Flightline Drive    
    Spring Branch, Texas   78070
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (830) 438-0395

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.001 par value   CJMB   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     
     

     

    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    Appointment of Interim Chief Financial Officer and Treasurer

     

    Effective as of December 1, 2025, the Callan JMB Inc., a Nevada corporation (the “Company”) appointed Christopher Shields, the Company’s Senior Vice President (Governmental Affairs), to serve as Interim Chief Financial Officer until a permanent Chief Financial Officer is appointed. Mr. Shields, age 57, has served as the Company’s Senior Vice President (Governmental Affairs), since April 15, 2025, pursuant to the employment agreement, dated March 15, 2025 (the “Employment Agreement”). Prior to joining the Company, Mr. Shields served as Assistant Commissioner (Bureau of Preparedness and Response) with Chicago Department of Public Health, City of Chicago, from February 2011 to March 2025, where he led City of Chicago’s efforts to prepare for and respond to the health consequences of disasters including severe weather, special events, infectious diseases, chemical/biological/radiological releases. Additionally, Mr. Shields has more than three decades of experience managing operations and logistics components of various stages and branches of public health emergency preparedness and response, among others. Mr. Shields received a B.S., in Community Health Administration in 1990 from Northern Illinois University, DeKalb, Illinois, and also completed the Critical Infrastructure Protection Certificate Program at the Texas A&M Engineering Extension Service (TEEX) between 2016 to 2017. Mr. Shields currently Shields serves on Northern Illinois University’s College of Health and Human Sciences Advisory Board.

     

    The Company has not yet determined any changes to Mr. Shields’s compensation as a result of his appointment as Interim Chief Financial Officer, and Mr. Shields shall continue to perform his services as disclosed in the Employment Agreement in addition to the current services, at an annual base salary of (i) $230,000 for the period from January 1, 2026, through December 31, 2026 and (ii) $260,000 for the period from January 1, 2027 through December 31, 2027 (the “Base Salary”). During the remainder of the Term, the Base Salary shall be reviewed by the Compensation Committee of the Board of Directors of the Company (the “Board”) and/or the Board each year, and the Board may, from time to time, increase such Base Salary. The Company also affords Mr. Shields the opportunity to earn an incentive bonus equal to thirty percent (30%) of the Base Salary for such fiscal year, payable to the extent the applicable performance goals are achieved (which goals and payment matrices set by the Compensation Committee of the Board in its discretion). Also, Mr. Shields received 100,000 options to purchase the Company’s common stock. Such options vest quarterly over a 24- month period starting 3 months from the effective date of the Employment Agreement. If any changes are to be made to Mr. Shields’ compensation as described herein, the Company will file an amendment to this Form 8-K containing such information within four business days after the information is determined or becomes available.

     

    There are no arrangements or understandings between Mr. Shields and any other persons pursuant to which Mr. Shields was elected to serve as Interim Chief Financial Officer. There are no family relationships between Mr. Shields and any director or executive officer of the Company, and there are no transactions between Mr. Shields and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    The following exhibits are being filed herewith:

     

    Exhibit No.   Description
    104   Cover Page Interactive Data File (embedded with the Inline XBRL document).

     

     
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: December 5, 2025 Callan JMB Inc.
         
      By: /s/ Wayne Williams
      Name: Wayne Williams
      Title: Chief Executive Officer

     

     

     

    Get the next $CJMB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CJMB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CJMB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update

    Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding Upgraded Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring SPRING BRANCH, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry

    11/14/25 4:05:00 PM ET
    $CJMB
    Real Estate

    Callan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility

    Agreement is the latest step in execution of the Company's strategy to support onshoring of logistical and operational activities for international companies to the U.S. SPRING BRANCH, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has entered a preliminary agreement with the maker of an oral drug delivery system to install its innovative manufacturing equipment in Callan JMB's cGMP facility in Texas, while the two companies negotiat

    11/13/25 9:00:00 AM ET
    $CJMB
    Real Estate

    Callan JMB Expands Logistics Platform Into Food Sampling Sector, Advancing Multi-Variant Growth Strategy

    Move leverages the Company's expertise in regulated materials to capture opportunities in sustainable, high-growth consumer markets Spring Branch, TX, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company serving healthcare and emergency management sectors through fulfillment, storage, monitoring, and cold chain logistics, today announced the expansion of its reclamation operations into the food sampling industry. This move is part of Callan JMB's multi-variant strategic growth initiative designed to extend its proven compliance-driven model into adjacent, high-growth markets. Building on a long history of excell

    11/10/25 8:45:00 AM ET
    $CJMB
    Real Estate

    $CJMB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, Chairman and President Williams Wayne D bought $73,499 worth of shares (44,545 units at $1.65) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/12/25 4:56:36 PM ET
    $CJMB
    Real Estate

    Director Duke Liberty Smith bought $2,334 worth of shares (1,512 units at $1.54) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/10/25 8:17:40 PM ET
    $CJMB
    Real Estate

    Chief Medical Officer Croyle David J bought $112,500 worth of shares (25,000 units at $4.50) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    4/3/25 4:36:02 PM ET
    $CJMB
    Real Estate

    $CJMB
    SEC Filings

    View All

    Callan JMB Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - CALLAN JMB INC. (0002032545) (Filer)

    12/8/25 3:11:50 PM ET
    $CJMB
    Real Estate

    SEC Form DEF 14A filed by Callan JMB Inc.

    DEF 14A - CALLAN JMB INC. (0002032545) (Filer)

    12/8/25 8:00:05 AM ET
    $CJMB
    Real Estate

    Callan JMB Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - CALLAN JMB INC. (0002032545) (Filer)

    12/5/25 5:00:27 PM ET
    $CJMB
    Real Estate

    $CJMB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, Chairman and President Williams Wayne D bought $73,499 worth of shares (44,545 units at $1.65) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/12/25 4:56:36 PM ET
    $CJMB
    Real Estate

    Director Duke Liberty Smith bought $2,334 worth of shares (1,512 units at $1.54) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/10/25 8:17:40 PM ET
    $CJMB
    Real Estate

    Chief Medical Officer Croyle David J bought $112,500 worth of shares (25,000 units at $4.50) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    4/3/25 4:36:02 PM ET
    $CJMB
    Real Estate

    $CJMB
    Leadership Updates

    Live Leadership Updates

    View All

    Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs

    Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency preparedness & response operations into new U.S. cities, states, and other countries. SPRING BRANCH, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced the appointment of former Assistant Commissioner of the Chicago Department of Public Health, Christ

    4/25/25 9:00:00 AM ET
    $CJMB
    Real Estate

    $CJMB
    Financials

    Live finance-specific insights

    View All

    Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update

    Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding Upgraded Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring SPRING BRANCH, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry

    11/14/25 4:05:00 PM ET
    $CJMB
    Real Estate

    Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update

    Formed a strategic partnership with Revival Health Inc. ("Revival") to deliver fully integrated supply chain services and infrastructure to support both the importation and onshore manufacturing of health, wellness, and longevity products Launched subsidiary in India and progressed to establish temperature-controlled warehouse for storage and distribution of pharmaceuticals at all temperature ranges Extended long-term contract with City of Chicago and received increase in funding Appointed Christopher Shields, former Assistant Commissioner of the Chicago Department of Public Health, as Senior Vice President, Emergency Preparedness & Response/Government Affairs Supported Texas and New Mex

    8/14/25 4:30:00 PM ET
    $CJMB
    Real Estate

    Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update

    Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option SPRING BRANCH, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its financial results for the full year ended December 31, 2024, and provided a business update. "2024 was a pivotal year for Callan JMB as we continued to deliver exceptional service to our diverse client base whil

    3/28/25 5:30:00 PM ET
    $CJMB
    Real Estate